HRP20171635T1 - Modificirani kolagen - Google Patents

Modificirani kolagen Download PDF

Info

Publication number
HRP20171635T1
HRP20171635T1 HRP20171635TT HRP20171635T HRP20171635T1 HR P20171635 T1 HRP20171635 T1 HR P20171635T1 HR P20171635T T HRP20171635T T HR P20171635TT HR P20171635 T HRP20171635 T HR P20171635T HR P20171635 T1 HRP20171635 T1 HR P20171635T1
Authority
HR
Croatia
Prior art keywords
collagen
temperature
providing
step consists
modified
Prior art date
Application number
HRP20171635TT
Other languages
English (en)
Inventor
Alexandra DIETRICH
Michael Myers
Original Assignee
Innocoll Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed by Innocoll Pharmaceuticals Limited filed Critical Innocoll Pharmaceuticals Limited
Publication of HRP20171635T1 publication Critical patent/HRP20171635T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (12)

1. Postupak priprave modificiranog kolagena, naznačen time što se postupak sastoji u koracima: (a) osiguravanja izoliranog kolagena; (b) smrzavanja izoliranog kolagena; (c) dehidratiranja smrznutog kolagena; i (d) zrenja dehidratiranog kolagena, gdje se korak zrenja sastoji u spremanju dehidratiranog kolagena na temperaturi od najmanje 40°C kroz najmanje šest tjedana, ili spremanju dehidratiranog kolagena na temperaturi od najmanje 65°C kroz najmanje tjedan dana, ili spremanju dehidratiranog kolagena na temperaturi od najmanje 30°C kroz najmanje dva mjeseca.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se korak osiguravanja sastoji u osiguravanju disperzije izoliranog kolagena s koncentracijom od 3-30 % (tež./tež.) čestica kolagena.
3. Postupak u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što se korak smrzavanja sastoji u smrzavanju na temperaturu od –33°C do –42°C.
4. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se korak dehidratiranja sastoji u uklanjanju vodene faze smanjivanjem tlaka na 0,05 do 0,5 mbar.
5. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se korak dehidratiranja sastoji u povećavanju temperature kolagena na +30°C.
6. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što korak dehidratiranja uključuje najmanje jedan korak uravnotežavanja, gdje se taj ili svaki korak uravnotežavanja sastoji u održavanju temperature na konstantnoj temperaturi kroz najmanje 10 minuta.
7. Postupak u skladu s patentnim zahtjevom 6, naznačen time što se korak dehidratiranja sastoji od šest koraka uravnotežavanja, gdje se svaki korak uravnotežavanja provodi kada temperatura poraste za 10°C.
8. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se modificirani kolagen melje prije koraka zrenja.
9. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se korak zrenja provodi uz relativnu vlažnost manju od 80%.
10. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što postupak dodatno uključuje korak osiguravanja lijeka kojem se dodaje zreli kolagen, ili koji se dodaje zrelom kolagenu, kako bi se osiguralo pripravak za unos lijeka s produljenim otpuštanjem.
11. Postupak u skladu s patentnim zahtjevom 10, naznačen time što je lijek vodena otopina lijeka.
12. Postupak proizvodnje pripravka koji sadrži modificirani kolagen, dobiven u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se postupak sastoji u koracima: (a) osiguravanja modificiranog kolagena postupcima u skladu s bilo kojim od prethodnih patentnih zahtjeva; (b) priprave vodene disperzije modificiranog kolagena dodavanjem zagrijane vode modificiranom kolagenu; (c) razgradnje vodene disperzije; i (d) dehidratiranja vodene disperzije.
HRP20171635TT 2012-01-09 2017-10-25 Modificirani kolagen HRP20171635T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
EP13700286.1A EP2802624B1 (en) 2012-01-09 2013-01-09 A modified collagen
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen

Publications (1)

Publication Number Publication Date
HRP20171635T1 true HRP20171635T1 (hr) 2018-02-23

Family

ID=47559477

Family Applications (3)

Application Number Title Priority Date Filing Date
HRP20171635TT HRP20171635T1 (hr) 2012-01-09 2017-10-25 Modificirani kolagen
HRP20190861TT HRP20190861T1 (hr) 2012-01-09 2019-05-09 Modificirani kolagen
HRP20210699TT HRP20210699T1 (hr) 2012-01-09 2021-05-05 Izmijenjeni kolagen

Family Applications After (2)

Application Number Title Priority Date Filing Date
HRP20190861TT HRP20190861T1 (hr) 2012-01-09 2019-05-09 Modificirani kolagen
HRP20210699TT HRP20210699T1 (hr) 2012-01-09 2021-05-05 Izmijenjeni kolagen

Country Status (21)

Country Link
US (4) US10487134B2 (hr)
EP (4) EP2802624B1 (hr)
JP (3) JP6494285B2 (hr)
AU (1) AU2013208952B2 (hr)
CA (1) CA2860552C (hr)
CY (3) CY1119524T1 (hr)
DK (3) DK3536748T3 (hr)
EA (2) EA037396B1 (hr)
ES (3) ES2870137T3 (hr)
HK (1) HK1244296B (hr)
HR (3) HRP20171635T1 (hr)
HU (3) HUE054838T2 (hr)
LT (3) LT3536748T (hr)
MX (1) MX368037B (hr)
NO (1) NO2802624T3 (hr)
PL (3) PL3536748T3 (hr)
PT (2) PT2802624T (hr)
RS (3) RS56564B1 (hr)
SI (3) SI3255106T1 (hr)
TR (1) TR201907156T4 (hr)
WO (1) WO2013104687A2 (hr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS56564B1 (sr) 2012-01-09 2018-02-28 Innocoll Pharm Ltd Modifikovan kolagen
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
WO2022219009A1 (en) 2021-04-12 2022-10-20 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
EP4376806A2 (en) * 2021-07-28 2024-06-05 Innocoll Pharmaceuticals Limited Bupivacaine-collagen drug delivery implant and methods of making and using thereof
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (hr) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) * 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) * 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
CA2277814A1 (en) * 1997-01-16 1998-07-23 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
PT2314293T (pt) * 2001-01-16 2017-04-11 Vascular Therapies Llc Dispositivo implantável que contém material de matriz reabsorvível e rapamicina para prevenir ou tratar doenças vasuloproliferativas
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
EP1616019B1 (en) * 2003-04-11 2008-12-10 Ecodynamic BioLab Inc. Method for extracting collagen comprising microbial fermentation
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
IES20080229A2 (en) 2007-03-28 2008-12-24 Innocoll Technologies Ltd A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US7820794B2 (en) 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
JP2012507383A (ja) * 2008-11-06 2012-03-29 イノコル テクノロジーズ リミティッド 薬剤送達インプラントおよびその作製のためのプロセス
CA2708844C (en) 2009-07-27 2016-01-05 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
US8951598B2 (en) 2010-05-07 2015-02-10 Empire Technology Development Llc Nanoscale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
RS56564B1 (sr) * 2012-01-09 2018-02-28 Innocoll Pharm Ltd Modifikovan kolagen
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Also Published As

Publication number Publication date
HRP20210699T1 (hr) 2021-09-17
EP3255106B1 (en) 2019-04-24
HUE054838T2 (hu) 2021-10-28
EA201790763A3 (ru) 2017-11-30
AU2013208952B2 (en) 2016-09-15
EP3255106A1 (en) 2017-12-13
ES2645445T3 (es) 2017-12-05
CY1124160T1 (el) 2022-05-27
JP7213205B2 (ja) 2023-01-26
RS61726B1 (sr) 2021-05-31
HUE037043T2 (hu) 2018-08-28
DK3255106T3 (da) 2019-05-20
EA027745B1 (ru) 2017-08-31
JP2015508403A (ja) 2015-03-19
PL3536748T3 (pl) 2021-07-19
US20150011476A1 (en) 2015-01-08
JP2019065017A (ja) 2019-04-25
US20220213173A1 (en) 2022-07-07
PT2802624T (pt) 2017-11-10
SI3255106T1 (sl) 2019-09-30
ES2728205T3 (es) 2019-10-22
LT3255106T (lt) 2019-07-25
PL3255106T3 (pl) 2019-09-30
US11746141B2 (en) 2023-09-05
JP2020169188A (ja) 2020-10-15
RS58935B1 (sr) 2019-08-30
JP6720279B2 (ja) 2020-07-08
EA201790763A2 (ru) 2017-07-31
CA2860552C (en) 2020-06-16
SI2802624T1 (en) 2018-02-28
LT3536748T (lt) 2021-08-10
CY1119524T1 (el) 2018-03-07
HUE043826T2 (hu) 2019-09-30
WO2013104687A3 (en) 2013-12-05
AU2013208952A1 (en) 2014-08-28
US20190359689A1 (en) 2019-11-28
DK3536748T3 (da) 2021-05-03
EP3536748B1 (en) 2021-02-24
LT2802624T (lt) 2017-12-27
PL2802624T3 (pl) 2018-02-28
WO2013104687A2 (en) 2013-07-18
EP3536748A1 (en) 2019-09-11
TR201907156T4 (tr) 2019-06-21
EP2802624B1 (en) 2017-08-02
HRP20190861T1 (hr) 2019-08-09
US20170022266A1 (en) 2017-01-26
RS56564B1 (sr) 2018-02-28
ES2870137T3 (es) 2021-10-26
EA037396B1 (ru) 2021-03-24
EP2802624A2 (en) 2014-11-19
JP6494285B2 (ja) 2019-04-03
EA201491278A1 (ru) 2015-01-30
MX2014008327A (es) 2015-05-11
HK1244296B (zh) 2020-06-05
MX368037B (es) 2019-09-17
SI3536748T1 (sl) 2021-08-31
US10487134B2 (en) 2019-11-26
CA2860552A1 (en) 2013-07-18
CY1121643T1 (el) 2020-07-31
NO2802624T3 (hr) 2017-12-30
PT3255106T (pt) 2019-06-04
DK2802624T3 (da) 2017-11-13
EP3901218A1 (en) 2021-10-27

Similar Documents

Publication Publication Date Title
HRP20171635T1 (hr) Modificirani kolagen
HRP20151263T1 (hr) Natrijeva sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
RU2017115489A (ru) Раствор, содержащий никотин в непротонированной форме и протонированной форме
MY178686A (en) Stabilizing composition for biological materials
NZ721424A (en) Source of phosphate for agriculture and the food industry
MX2013013819A (es) Procedimiento para la extraccion de pectina.
CN105288634A (zh) 一种甘油-氨基酸低共熔溶剂的制备方法
NZ741421A (en) Methods for freeze-drying and rehydrating biologics
RU2015138773A (ru) Обработка табака
CN102626239A (zh) 一种黄鱼鲞的加工工艺
RU2018112431A (ru) Лиофилизированный препарат альгиновой кислоты
RU2011153245A (ru) Способ формирования защитного покрытия для хранения объектов водных биологических ресурсов с использованием модифицированных защитных покрытий
EA201201518A1 (ru) Способ получения па-410 и па-410, получаемый таким способом
CN103896718A (zh) 三氯乙烷的回收方法
RU2016129070A (ru) Способы получения биополимеров с заданной средней молекулярной массой
PL409976A1 (pl) Sposób otrzymywania dodatku do żywności do stabilizacji tekstury albo zagęszczania, zwłaszcza z wytłoków jabłkowych oraz dodatek otrzymany tym sposobem
서혜진 et al. Preparation and Properties of Zinc Calcium Alginate Films according to Concentration
TH120268B (th) องค์ประกอบและวิธีการในการยับยั้งการตอบสนองต่อเอทิลีนในพืชไร่ที่ใช้เกลือ 3-โซโคลโพรพิล-1อีนิล-โพรพาโนอิก โซเดียม
TH141704A (th) กระบวนการเพื่อผลิตองค์ประกอบอนุภาคซึ่งประกอบรวมด้วย 2-o-อัลฟา-d-กลูโคซิล-l-แอสคอร์บิกแอซิดชนิดผลึกปราศจากน้ำ
RU2011154445A (ru) Способ замораживания свежих ягод
CN106106711A (zh) 一种黄花梨保鲜方法
RU2015130997A (ru) Способ обработки корнеклубнеплодов растений для хранения
MX2015007686A (es) Un polvo de colageno.
RU2010108607A (ru) Способ консервирования томатов маринованных
UA82330U (ru) Способ получения калимагнезии и бишофита из растворов хлоридно-сульфатного типа